Bristol melanoma drug extends survival in study | Reuters

Links shared publicly online about this topic.

421
total visits

Bristol melanoma drug extends survival in study | Reuters

NEW YORK (Reuters) - Bristol-Myers Squibb Co's eagerly anticipated experimental drug ipilimumab extended survival of previously untreated patients with advanced melanoma in a late stage study, the company

View full resource at reuters.com

Tags: Cancer, Skin Cancer, Melanoma, Drug, Bristol-Myers Squibb

Most Recently Shared on March 23, 2011 at 1:31 am By:

Skin Cancer OW

Bristol melanoma drug extends survival in study: NEW YORK (Reuters) - Bristol-Myers Squibb Co's eagerly anticipa... http://bit.ly/ePuJaU

1 year ago...

Retweet

Favorite

Also Shared By:

Medical News

HealthIT Policy

Brad Lipson, DO

WRAPUP 2-New melanoma drugs improve chances of survival | Reuters

reuters.com — “* Roche, Bristol-Myers drugs improve survival * Melanoma experts call studies unprecedented (Adds analyst comments, other details) By Julie Steenhuysen and Deena Beasley CHICAGO, June 5 (Reuters)” View full resource at reuters.com

Most Recently Shared on June 5, 2011 at 8:03 pm By:

EnlightenMed was founded by Dr. Steven Eisenberg, a board certified doctor of Internal Medicine, Medical Oncology and Hematology. He has five cancer centers in the Southern California cities of Poway, Escondido, Vista, Encinitas and La Jolla. Dr. Eisenberg uses music, humor and heart to transform his patients’ journeys through the minefield of cancer.

Here’s his story:

I became a medical oncologist because I’ve always felt there was more to taking care of cancer patients than just ordering tests, devising treatment plans, pushing chemotherapy, comparing CT scans, and giving bad news to people. I wanted to help patients feel better using the wisdom of their body and mind to reduce stress during treatments in the present moment.

It takes a lot more than a traditional Western approach to medicine to treat cancer. I believe in a holistic approach to healing that integrates techniques drawing on yoga, acupuncture and meditation. I encourage patients to incorporate psychotherapy and educate them about the importance of nutrition. I also believe in the importance and power of connection in healing. And for me, I connect with my patients through music.

I discovered musician Peter Himmelman while I was in medical school in Philly. I’d see him perform live whenever possible, and was inspired by his rapport with his audience. He’d pick someone out in the crowd, and write a song about them on the spot. It occurred to me, why not try this with my patients? So I brought my guitar into the chemo room, and started singing. I’d sing silly songs, anything to help my patients laugh, and think about something other than their sickness.

One day a friend told me about a contest Peter Himmelman was having. You had to write in and say how Peter’s music had impacted you. The prize was that Peter would write a song about you. I entered, I won, and Peter wrote a song about me. I had no idea how powerful that was going to be for me. During that same time in my life, I was facing a health scare of my own. Everything turned out to be fine, but having a song that was my song, telling my story, was a source of real strength for me in a difficult time. Everything changed after that. I knew that I wanted to connect with my patients through song, and help them tell their stories.

After all of the grueling tests and analyses have been completed, I sit with most of my patients and ask them what makes them happy, what means the most to them — what moves, touches and inspires them. Then together, we write a song. For a lot of my patients, it becomes a personal anthem in their fight against this deadly disease.

I started EnlightenMed and it's first program, Lyrical Life, because I believe there’s a message in all of this that is much bigger than just songwriting. I’ve seen in my practice and in my own life how important it is to have that connection with someone when you need it most. I want to empower people to reach out to those that need it most, connect with them, create something with them, listen to them. I think when we come together we’re capable of great things, and I hope EnlightenMed can help bridge those connections." /> Dr. Steven G. Eisenberg Oncologist, Hematologist, Physician, Active Health Library, and Doctor

RT @shelleypetersen: Roche & Daiichi Sankyo #melanoma #drugs studies "unprecedented" http://t.co/ylj0u3R #healthinnovations #cancer #ASCO11

11 months ago...

Retweet

Favorite

Melanoma drug extends life in second large study | Reuters

reuters.com — “CHICAGO (Reuters) - People with advanced melanoma who were treated with Bristol-Myers Squibb Co's Yervoy plus chemotherapy lived an average of two months longer than people who got chemotherapy alone,” View full resource at reuters.com

Most Recently Shared on June 5, 2011 at 2:58 pm By:

Reuters Health Health News

Melanoma drug extends life in second large study http://reut.rs/k3DV0l

11 months ago...

Retweet

Favorite

Bristol melanoma drug extends survival in study | Reuters

reuters.com — “NEW YORK (Reuters) - Bristol-Myers Squibb Co's eagerly anticipated experimental drug ipilimumab extended survival of previously untreated patients with advanced melanoma in a late stage study, the company” View full resource at reuters.com